The IFPMA Welcomes Nicholas Piramal India Limited

Main Category: Pharmacy / Pharmacist
Article Date: 29 Sep 2007 - 19:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is pleased to announce that its newest member company is Nicholas Piramal India Ltd..

Dr. Harvey Bale, Director General of the IFPMA, said: "We very much welcome Nicholas Piramal, not only as our newest member, but also as our first pharmaceutical company member from India. Piramal's membership of the IFPMA underlines that, in the future, research-based pharmaceutical leadership will not be the exclusive preserve of companies from Europe, Japan or the United States."

Nicholas Piramal India Limited has novel lead compounds in the fields of oncology, inflammation, infectious diseases and diabetes. Its comprehensive R&D organization covers a wide range of activities, including natural products (microbial and plant extracts), herbs (Indian traditional medicinal plants), medicinal and synthetic chemistry, special projects (looking at medicine combinations), cheminformatics (compound libraries, software tools and modeling), process development, pharmacology, drug metabolism and pharmacokinetics, molecular biology, biomarkers and clinical research. In July 2007, the US FDA approved Nicholas Piramal's Investigational New Drug (IND) application for its lead cancer compound P 276-00 to treat Multiple Myeloma. Nicholas Piramal is publicly committed to strong and effective intellectual property rights.

For more information on Nicholas Piramal, please go to: http://www.nicholaspiramal.com

About the IFPMA

The International Federation of Pharmaceutical Manufacturers & Associations is a non-profit, non-governmental organisation representing national industry associations and companies from both developed and developing countries. Member companies of the IFPMA are research-based pharmaceutical, biotech and vaccine companies.

http://www.ifpma.org

Article adapted by Medical News Today from original press release.
Visit our pharmacy / pharmacist section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
IFPMA. "The IFPMA Welcomes Nicholas Piramal India Limited." Medical News Today. MediLexicon, Intl., 29 Sep. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/83981.php>

APA
IFPMA. (2007, September 29). "The IFPMA Welcomes Nicholas Piramal India Limited." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/83981.php.

Please note: If no author information is provided, the source is cited instead.


Pharmacy / Pharmacist

Most Popular Articles



Follow Our Pharmacy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharmacy / Pharmacist Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »